CUMYL-NBMINACA

CUMYL-NBMINACA (SGT-152, Cumyl-BC[2.2.1]HpMINACA) is a synthetic cannabinoid compound first reported in a 2013 patent,^[1] but not identified as a designer drug until 2021, being identified by a forensic laboratory in Germany in February 2021.^[2][3]

CUMYL-NBMINACA

Identifiers
IUPAC name [1-(bicyclo[2.2.1]heptan-2-yl)methyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide
CAS Number	1631074-60-6
PubChem CID	117650372
ChemSpider	115005719
CompTox Dashboard (EPA)	DTXSID401342013
Chemical and physical data
Formula	C25H29N3O
Molar mass	387.527 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(C)(C1=CC=CC=C1)NC(=O)C2=NN(C3=CC=CC=C32)CC4CC5CCC4C5
InChI InChI=1S/C25H29N3O/c1-25(2,20-8-4-3-5-9-20)26-24(29)23-21-10-6-7-11-22(21)28(27-23)16-19-15-17-12-13-18(19)14-17/h3-11,17-19H,12-16H2,1-2H3,(H,26,29) Key:MLRLLZWQYJJPEX-UHFFFAOYSA-N

See also

• CUMYL-BC-HPMEGACLONE-221
• CUMYL-3TMS-PRINACA